Drug intelligence / Profile preview

loviride

Development stage
Discontinued
Lead developer
Johnson & Johnson
Modality
Small Molecules
01

Overview

Loviride is an experimental small molecule compound with the chemical formula C17H16Cl2N2O2 and a molecular weight of 351.227. It belongs to the class of alkyl phenylketones and features both dichlorophenyl and acetylanilino moieties. Loviride was investigated as a non-nucleoside reverse transcriptase inhibitor (NNRTI), primarily for its potential use in HIV therapy; however, it has not been approved for clinical use or advanced beyond early-stage research[1][3]. No current indications or approved uses are listed.

Other names
α-(2,6-dichlorophenyl)-α-(2-acetyl-5-methylanilino)acetamide(2S)-2-[(2-acetyl-5-methylphenyl)amino]-2-(2,6-dichlorophenyl)acetamide
02

Targets

Human immunodeficiency virus type 1 reverse transcriptase

Beyond the preview

Go deeper on loviride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on loviride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call